What is the most common organism in adult spontaneous bacterial peritonitis (SBP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Common Organism in Adult Spontaneous Bacterial Peritonitis

Escherichia coli (E. coli) is the most common organism causing spontaneous bacterial peritonitis (SBP) in adults with cirrhosis. 1

Microbiology of SBP

  • SBP is typically monomicrobial and most commonly caused by gram-negative aerobic bacteria, with E. coli being the predominant pathogen (occurring in approximately 32-67% of culture-positive cases) 1, 2
  • Other common causative organisms include:
    • Klebsiella species 1
    • Streptococcus species 1
    • Enterococcus species (found in approximately 15.7% of cases) 1

Changing Epidemiology of SBP

  • Recent studies have shown a shift in the microbial spectrum of SBP with increasing prevalence of gram-positive organisms, particularly in healthcare settings 3, 4

  • In nosocomial (hospital-acquired) SBP, there is a higher prevalence of:

    • Enterococcus species 1
    • Staphylococcus species 1, 4
    • Enterobacter species 1
  • The epidemiology differs between community-acquired and nosocomial infections:

    • Community-acquired SBP: Gram-negative bacteria predominate (especially E. coli) 1
    • Nosocomial SBP: Gram-positive infections are more common 1

Antibiotic Resistance Patterns

  • There is increasing resistance to quinolones among gram-negative bacteria in SBP, with approximately 30% of isolated gram-negative bacteria being resistant to quinolones 1
  • In patients on norfloxacin prophylaxis, SBP is more likely to be caused by quinolone-resistant gram-negative bacteria or gram-positive cocci 1
  • The rate of cephalosporin-resistant gram-negative bacteria remains relatively low in patients with SBP 1

Clinical Implications

  • Third-generation cephalosporins remain the first-line empirical treatment for community-acquired SBP due to their effectiveness against E. coli and other common pathogens 1
  • For patients who develop SBP while on quinolone prophylaxis, cefotaxime or amoxicillin/clavulanic acid are recommended 1
  • In healthcare settings or for nosocomial SBP, broader coverage may be needed due to the higher prevalence of resistant organisms 1, 3

Common Pitfalls to Avoid

  • Failing to perform diagnostic paracentesis in all cirrhotic patients with ascites admitted to the hospital, as SBP may be asymptomatic in up to one-third of cases 1
  • Not considering the possibility of secondary bacterial peritonitis (due to intestinal perforation) when multiple organisms are isolated from ascitic fluid 1
  • Using quinolones empirically in patients already on quinolone prophylaxis or in areas with high quinolone resistance 1
  • Delaying antibiotic treatment while waiting for culture results, as prompt empiric therapy is essential for improving outcomes 1, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Empiric Antibiotic Therapy for Gastric Perforation and Peritonitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.